To the Editor: Patients with psoriasis are at increased risk of developing non melanoma skin cancer (NMSC), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).1,2 The risk is especially elevated among those who previously received systemic treatment or phototherapy.2 Systemic treatments, including biologic therapies and methotrexate (MTX), are effective in managing immune-mediated diseases; however, they may increase susceptibility to NMSC due to immunosuppression or other factors.3
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
skin cancer
8
patients psoriasis
8
cell carcinoma
8
non-melanoma skin
4
cancer risk
4
risk patients
4
psoriasis longitudinal
4
longitudinal assessment
4
assessment registry
4
registry psolar
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!